These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6867005)

  • 1. Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine.
    Mufson MA; Krause HE; Schiffman G
    Proc Soc Exp Biol Med; 1983 Jun; 173(2):270-5. PubMed ID: 6867005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal antibody levels one decade after immunization of healthy adults.
    Mufson MA; Krause HE; Schiffman G; Hughey DF
    Am J Med Sci; 1987 May; 293(5):279-84. PubMed ID: 3591818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine.
    Mufson MA; Krause HE; Schiffman G
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):220-5. PubMed ID: 6483857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children.
    Obaro SK; Huo Z; Banya WA; Henderson DC; Monteil MA; Leach A; Greenwood BM
    Pediatr Infect Dis J; 1997 Dec; 16(12):1135-40. PubMed ID: 9427458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics.
    Beam TR; Crigler ED; Goldman JK; Schiffman G
    JAMA; 1980 Dec; 244(23):2621-4. PubMed ID: 7431608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal polysaccharide immunization in infants and children.
    Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
    Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children.
    Pedersen FK; Henrichsen J; Schiffman G
    Acta Paediatr Scand; 1982 May; 71(3):451-5. PubMed ID: 7136661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides.
    Johnson S; Opstad NL; Douglas JM; Janoff EN
    Infect Immun; 1996 Oct; 64(10):4339-44. PubMed ID: 8926108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
    Austrian R
    J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus.
    McDonald E; Jarrett MP; Schiffman G; Grayzel AI
    J Rheumatol; 1984 Jun; 11(3):306-8. PubMed ID: 6737372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radioimmunoassay for antibody to pneumococcal polysaccharides.
    Latif AA; Webster AD
    J Immunol Methods; 1982; 49(1):83-8. PubMed ID: 7061872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of patients with Sjögren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial.
    Karsh J; Pavlidis N; Schiffman G; Moutsopoulos HM
    Arthritis Rheum; 1980 Nov; 23(11):1294-8. PubMed ID: 7004446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
    Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
    Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to pneumococcal polysaccharides in insulin-dependent diabetes mellitus.
    Lederman MM; Rodman HM; Schacter BZ; Jones PK; Schiffman G
    Diabetes Care; 1982; 5(1):36-9. PubMed ID: 6754301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination.
    Penn RL; Lewin EB; Douglas RG; Schiffman G; Lee CJ; Robbins JB
    Infect Immun; 1982 Jun; 36(3):1261-2. PubMed ID: 7095850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Barrett DJ; Ayoub EM
    Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine.
    Mufson MA; Hughey D; Lydick E
    J Infect Dis; 1985 Apr; 151(4):749-50. PubMed ID: 3973424
    [No Abstract]   [Full Text] [Related]  

  • 18. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants.
    Koskela M; Leinonen M; Häivä VM; Timonen M; Mäkelä PH
    Pediatr Infect Dis; 1986; 5(1):45-50. PubMed ID: 3945575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.
    Molrine DC; George S; Tarbell N; Mauch P; Diller L; Neuberg D; Shamberger RC; Anderson EL; Phillips NR; Kinsella K; Ambrosino DM
    Ann Intern Med; 1995 Dec; 123(11):828-34. PubMed ID: 7486464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
    Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
    Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.